Liposomal amphotericin B as a treatment for human leishmaniasis. (Record no. 22279287)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01455 a2200409 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516122254.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201305s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1744-7623 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1517/14728214.2012.748036 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Balasegaram, Manica |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20130501 |
245 00 - TITLE STATEMENT | |
Title | Liposomal amphotericin B as a treatment for human leishmaniasis. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Expert opinion on emerging drugs |
Date of publication, distribution, etc. | Dec 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 493-510 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Amphotericin B |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antiprotozoal Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Design |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drugs, Generic |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Health Services Accessibility |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leishmaniasis |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leishmaniasis, Visceral |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Therapeutic Equivalency |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ritmeijer, Koert |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lima, Maria Angeles |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Burza, Sakib |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ortiz Genovese, Gemma |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Milani, Barbara |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gaspani, Sara |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Potet, Julien |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chappuis, François |
773 0# - HOST ITEM ENTRY | |
Title | Expert opinion on emerging drugs |
Related parts | vol. 17 |
-- | no. 4 |
-- | p. 493-510 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1517/14728214.2012.748036">https://doi.org/10.1517/14728214.2012.748036</a> |
Public note | Available from publisher's website |
No items available.